Login / Signup
[The immunocytokine FAP-IL2v : a potent co-therapy for preventing resistance to trastuzumab in HER2 + breast cancer].
Eléonore Parisel
Laura Prudhomme
Jonathan Pol
Published in:
Medecine sciences : M/S (2024)
Keyphrases
</>
epidermal growth factor receptor
anti inflammatory
young adults